Dexcom Inc
NASDAQ:DXCM
Dexcom Inc
Net Income (Common)
Dexcom Inc
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Dexcom Inc
NASDAQ:DXCM
|
Net Income (Common)
$639.3m
|
CAGR 3-Years
3%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Net Income (Common)
$1.2B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
3%
|
|
Boston Scientific Corp
NYSE:BSX
|
Net Income (Common)
$1.8B
|
CAGR 3-Years
106%
|
CAGR 5-Years
0%
|
CAGR 10-Years
17%
|
|
Stryker Corp
NYSE:SYK
|
Net Income (Common)
$3.4B
|
CAGR 3-Years
34%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
16%
|
|
Abbott Laboratories
NYSE:ABT
|
Net Income (Common)
$5.6B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
17%
|
CAGR 10-Years
9%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Net Income (Common)
$2B
|
CAGR 3-Years
19%
|
CAGR 5-Years
12%
|
CAGR 10-Years
14%
|
See Also
What is Dexcom Inc's Net Income (Common)?
Net Income (Common)
639.3m
USD
Based on the financial report for Mar 31, 2024, Dexcom Inc's Net Income (Common) amounts to 639.3m USD.
What is Dexcom Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 3Y
3%
Over the last year, the Net Income (Common) growth was 119%. The average annual Net Income (Common) growth rates for Dexcom Inc have been 3% over the past three years .